12 Nov 2021 --- Nuritas has raised US$45 million in a series B funding round, which it aims to use toward expanding its global growth and building its US headquarters. According to the Ireland-based company, a key focus will be scaling its peptide discovery platform. Its total funding to date is US$75 million.
